Jubilant Pharmova has acquired a 25.21 per cent stake in Greencure at a cost of Rs 8.75 crore.

Greencure products have differentiated positioning, combining the best of Ayurveda and German herbal science. The company has obtained multiple international certifications to strengthen their credibility. The market is being driven by a growing shift towards natural products, as well as rise in chronic diseases and growing health awareness. There is also a strong synergy between Jubilant and Greencure with respect to OTC portfolio which can be explored for R&D, online acceleration and offline distribution.